Your browser doesn't support javascript.
loading
Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.
Prost, Stéphane; Relouzat, Francis; Spentchian, Marc; Ouzegdouh, Yasmine; Saliba, Joseph; Massonnet, Gérald; Beressi, Jean-Paul; Verhoeyen, Els; Raggueneau, Victoria; Maneglier, Benjamin; Castaigne, Sylvie; Chomienne, Christine; Chrétien, Stany; Rousselot, Philippe; Leboulch, Philippe.
Afiliação
  • Prost S; CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), F-92265 Fontenay-aux-Roses, France.
  • Relouzat F; CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), F-92265 Fontenay-aux-Roses, France.
  • Spentchian M; Département de biologie médicale, Hôpital Mignot, F-78150 Le Chesnay, France.
  • Ouzegdouh Y; CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), F-92265 Fontenay-aux-Roses, France.
  • Saliba J; CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), F-92265 Fontenay-aux-Roses, France.
  • Massonnet G; Unité de Biologie Cellulaire, UMR-S-940 Institut Universitaire d'Hématologie, Hôpital Saint Louis, F-75010 Paris, France.
  • Beressi JP; Service d'Endocrinologie et de Diabétologie, Hôpital Mignot, F-78150 Le Chesnay, France.
  • Verhoeyen E; CIRI, International Center for Infectiology Research, EVIR team, Inserm, U1111, CNRS, UMR5308, Université de Lyon-1, ENS de Lyon, 69007 Lyon, France.
  • Raggueneau V; Inserm, U895, Centre de Médecine Moléculaire (C3M), équipe 3, 06204 Nice, France.
  • Maneglier B; Laboratoire d'hématologie, Centre Hospitalier de Versailles, F-78150 Le Chesnay, France.
  • Castaigne S; Unité de Pharmacologie, Service de Biologie Médicale, Centre Hospitalier de Versailles, F-78150 Le Chesnay, France.
  • Chomienne C; Service d'Hématologie et d'Oncologie, Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, F-78150 Le Chesnay, France.
  • Chrétien S; Unité de Biologie Cellulaire, UMR-S-940 Institut Universitaire d'Hématologie, Hôpital Saint Louis, F-75010 Paris, France.
  • Rousselot P; CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), F-92265 Fontenay-aux-Roses, France.
  • Leboulch P; Inserm, Institute of Emerging Diseases and Innovative Therapies (iMETI), F-92265 Fontenay-aux-Roses, France.
Nature ; 525(7569): 380-3, 2015 Sep 17.
Article em En | MEDLINE | ID: mdl-26331539
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Células-Tronco Neoplásicas / Benzamidas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Tiazolidinedionas / PPAR gama Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Células-Tronco Neoplásicas / Benzamidas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Tiazolidinedionas / PPAR gama Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França